IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.1727
+0.0067 (4.04%)
At close: Apr 1, 2025, 4:00 PM
0.1799
+0.0072 (4.17%)
After-hours: Apr 1, 2025, 7:54 PM EDT

IN8bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
1419605782-
Upgrade
Market Cap Growth
-68.76%-68.76%5.43%-31.25%--
Upgrade
Enterprise Value
820523444-
Upgrade
Last Close Price
0.170.261.382.314.39-
Upgrade
PB Ratio
0.831.292.392.492.16-
Upgrade
P/TBV Ratio
1.291.292.392.492.16-
Upgrade
Debt / Equity Ratio
0.350.350.200.260.060.01
Upgrade
Quick Ratio
3.613.613.953.1216.417.00
Upgrade
Current Ratio
4.084.084.573.8217.287.05
Upgrade
Return on Equity (ROE)
-154.44%-154.44%-125.90%-93.64%-51.87%-91.01%
Upgrade
Return on Assets (ROA)
-67.70%-67.70%-56.81%-47.37%-29.01%-48.53%
Upgrade
Return on Capital (ROIC)
-74.99%-74.99%-64.89%-51.52%-31.00%-56.36%
Upgrade
Earnings Yield
-219.05%-163.26%-50.29%-50.39%-17.80%-
Upgrade
FCF Yield
-175.14%-130.54%-40.12%-49.16%-16.78%-
Upgrade
Buyback Yield / Dilution
-79.30%-79.30%-42.43%-110.32%-191.59%-7.24%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q